Société Launches First Non-Irritating Vitamin C Product for All Skin Types
Société's Triple C Serum delivers the most stable and highest concentration of Vitamin C in the world
Atlanta, GA (PRWEB) February 18, 2013
You have to “C” it to believe it. Until now, a more acidic form of Vitamin C has traditionally been delivered in a lower pH product, causing irritation and limiting consumer use. Société Clinical Skincare's newest product, Triple C Serum, combines the three most stable forms of Vitamin C available in a neutral (non-acidic), non-irritating form, making the benefits of Vitamin C available to all skin types.
Why is Vitamin C important? Vitamin C is an antioxidant and is a key in the fight against aging. When applied to the skin, Vitamin C stimulates cell renewal, collagen and elastin production and increases healthy circulation. It also boosts your skin's natural immune properties and helps minimize damage caused by free radicals found in the environment – free radicals accelerate skin damage and the wrinkles associated with premature aging. Additionally, Vitamin C helps brighten the skin, removing discoloration caused from years of sun exposure.
“This is so much more than a Vitamin C serum,” said Denise Byrnes, product development officer and co-founder of Société Clinical Skincare. “We've been working with various formulations and technologies to ensure that we include the most stable and highest doses of Vitamin C available in the world, and we believe we have done this successfully. Société's Triple C is an amazingly effective, complex skincare product that reverses the effects of living in a complex and damaging environment. This product is designed to provide maximum results.”
Here's why the product works:
- Triple C Serum uses a water-based (not lipid-based) delivery system that won't clog pores or cause breakouts – most serums are lipid-based.
- Less acidic forms of all three Vitamin Cs are used to avoid irritation or acidic inflammation oftentimes experienced with other products.
- It is gentle enough for use on all skin types, including aging, sun-damaged, pigmented, acneic, dry/sensitive (Rosacea) and post-procedure, and is safe for use during pregnancy.
- To further increase the product's effectiveness, apple stem cells, peptides and increase the vitality of the skins own stem cells and combat aging in the skin.
- With 7 DNA repair mechanisms, not only is hyperpigmentation drastically reduced, but damaged cells can repair themselves, restoring skin to a healthier state.
o DNA repair agents like DN-Age, (a.k.a., Cassia Alata Leaf Extract) help heal the skin and reduce deep photo damage caused by UV radiation, at both the nuclear and mitochondrial levels.
- Peptides like Matrixyl 3000 and Syn-Coll smooth fine lines and wrinkles, while boosting collagen production.
“Through the years, I've tried numerous Vitamin C products and have yet to find one that works for all skin types,” said Ms. Saira Ali of Urban Retreat Skin Center in Houston Texas. “Until now, that is. Société's Triple C Serum will work on patients with prior Vitamin C sensitivities, and allow them to experience noticeable improvements in the health, appearance and texture of their skin. The research and testing Société puts into its products is reflected in the quality and effectiveness of their entire skin care line.”
“My skin has always been sensitive and unable to tolerate most products – ones with vitamin C in particular,” said Kathy Pillatt, Société customer from Brunswick, Ohio. “The acidity in Vitamin C irritated my skin and I've been continually disappointed, mainly because I know how good it is for the skin when applied topically. I was hesitant to try anything new but I took a chance, and Société's Triple C Vitamin Therapy serum is a dream come true for me. After two weeks of using it, my skin was, and still is, noticeably smoother and softer, and amazingly, calmer. I'm hooked!”
Société's new Triple C Serum further strengthens its expanding clinical skincare product line and is available for pre-order now.
Developed and tested in a clinical setting, Société's unique formulations contain high performance, patent-pending ingredients and are paraben free, propylene glycol free and sodium lauryl sulfate free – and further-reinforce the nexus between science and skincare.
Société is available only through a physician's office and uses a customized approach to treating a variety of skin types, including hyperpigmentation, acne-prone, hypersensitive and aging skin. This delivery system puts the professional in control of patient results, removing the ‘self treatment/self diagnosis' that oftentimes reaps lackluster results. Visit http://www.Societeskincare.com to view the full line of Société's products and peels.
About Société Clinical Skin Care, LLC
Founded in Atlanta, GA in 2008, Société Clinical Skin Care's exclusive products are created with the professional skin care specialist in mind. Developed and tested in a clinical setting, the innovative formulations contain high performance, patent-pending ingredients that are free of parabens, propylene glycol and sodium lauryl sulfate. The Société Transition Peel System is a customized approach for treating a variety of skin types, putting the skin care professional back in control of patient results. Sold solely through the physician community the Société line is easy to prescribe and designed to increase overall patient satisfaction while maximizing clinic profits.
Société products are distributed domestically in the United States, and internationally in five countries, with additional distribution and product line expansion planned throughout 2013.
One of Société's core priorities is its environmental impact, which is taken into account throughout all facets of the business, including: recyclable product packaging, eco-friendly ingredients, recycling, paperless systems and renewable energy. For more information, visit http://www.Societeskincare.com or http://www.facebook.com/Societeskincare.
Cheryl Monkhouse, Public Relations Director
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/2/prweb10443624.htmAdvertisement